Terbutaline pump maintenance therapy for prevention of preterm delivery: a double-blind trial
Article Abstract:
Terbutaline pump therapy may not prolong the time to delivery in women at risk of delivering prematurely. Intravenous magnesium had suppressed preterm labor in fifty-two women. Subsequently, 24 women received terbutaline pump therapy and 28 women received placebo. Time to delivery, birth rates and infant characteristics were similar in both groups. This finding negated a terbutaline effect.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Vaginal sonography and cervical incompetence
Article Abstract:
Research has been conducted on cervical incompetence characterized by spontaneous midtrimester birth and recurrent painless dilation. The authors believe that women with the history of spontaneous preterm birth should undergo a trial for cerclage which is underway.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A randomized, double-blind trial of prostaglandin E2 gel for cervical ripening and meta-analysis. A prospective randomized study of saline solution amnioinfusion
- Abstracts: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. part 2
- Abstracts: A double-blind, randomized trial of 0.05 percent podofilox and placebo for the treatment of genital warts in women
- Abstracts: Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Long-term effects of inhaled corticosteroids on FEV(sub 1) in patients with chronic obstructive pulmonary disease: a meta-analysis
- Abstracts: The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy. part 2